Four Thalassemia major Kids Treated Through Unrelated Donor BMT at Narayana Health City

IMT News Desk
IMT News Desk
· 4 min read
Dr. Sunil Bhat, Senior Consultant and Head of Paediatric Haematology and Dr. Shobha Badiger, Consultant Oncology, Narayana Health City with the kids and their parents

Narayana Health City treats four Sri Lankan children suffering from thalassemia major, a life-threatening disorder, through unrelated donor bone marrow transplant. The doctors sourced matching bone marrow cells from unrelated donors from across the world and carried out the transplants at Bone Marrow Transplant Unit at the Mazumdar Shaw Cancer Centre, Narayana Health City. Patients included, 15 months old Nethumi Shenaya Rajapaksha Bomaluwe, 4-year-old Suwini Umeda Shreemali Balasooriya, 5-year-old Purna and 10-year-old Mithun Dilesh Welgamage.

Thalassemia major is a rare genetic blood disorder wherein, the body fails to produce enough red cells and the ones that are formed also die soon resulting in very low haemoglobin levels. These patients need lifelong blood transfusion and lifespan is very short. Sri Lanka faces several challenges while dealing with complex cases, especially those who don’t have any family matched donors for transplant and Narayana Health City offered to help. The common treatment for thalassemia major is blood transfusion. However, the continuous transfusions can cause complications like iron overload and blood- borne infections. Bone marrow transplant is the curative option and hence the families of the four Sri Lankan children decided to opt for this treatment modality.

For Narayana Health City, it was a challenge to meet, as all previous attempts elsewhere to find matching bone marrow donors in the families of these children had failed. Fortunately, the team could find matching donors for all four children. While Suwini and Purna found saviours in Datri Registry (India), the other two found matching donors from German Registry (DKMS) in London.

Elaborating about the treatment, Dr. Sunil Bhat, Senior Consultant and Head of Paediatric Haematology, Oncology and Bone Marrow Transplant at Narayana Health City,  said, “Apart from finding human leukocyte antigen (HLA) matched donors for all the 4 children the biggest challenge was to ensure acceptance of the stem cells by the recipient’s system. In unrelated bone marrow transplant, unlike in related donors, the genetic makeup and immune systems in the recipient and the donor are very different. Hence the chances for complications both during and post-transplant are very high. Fortunately, in the case of these children their body responded very positively to the transplant and that has helped us to cure them of thalassemia major. He also pointed out that the chances of finding matched donors are far better from same ethnic background. As there are no unrelated donor registries in Sri Lanka, finding a donor for them is a challenge”

Over the years, cases such as these have propelled Narayana Health City to be the most sought-after health destination for both national and international patients. With its state-of-the-art facilities and experienced doctors, Narayana Health has not only become a center of excellence for heart problems, which it already has earned a name for, but a leading referral centre for a wide array of treatments including bone marrow transplant.

Sharing his joy, Jayantha Balasooriya, father of Suwini Umeda Shreemali Balasooriya, who is the Secretary of The Thalassemia Society as well said, “Back home thalassemia major is considered as an incurable disease especially for children who do not have related donors. The children depend on blood transfusion and thereby succumb to fatalities very early in life. Thankfully, we happened to hear about the bone marrow transplant unit at Narayana Health City. We are grateful to Dr. Sunil Bhat and the entire team for not only curing my daughter but also the children of my friends from this dreadful disease.” Mr Balasooriya also emphasised the need for donor registry in Sri Lanka and having such expertise there in order to help more and more patients.

The Bone Marrow Transplant Unit at the Mazumdar Shaw Cancer Centre, Narayana Health City, is recognized world-over as a leading referral centre for both autologous and allogenic stem cell transplant. The unit has completed more than 775 stem cell transplants, including the complex transplants like haploidentical (half matched transplants) and unrelated transplants.

Read Next

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  
News
May 19, 2026

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  

Zydus Wellness Limited reported a consolidated growth of 62.1% in Net Sales, which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year. The Company reported annual Net Sales of Rs. 39,400 million, with a y-o-y growth of 46.4% in FY 26. EBITDA for the period […]
Article by: IMT News Desk
Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%
News
May 19, 2026

Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%

Strides Pharma Science Ltd. reported a robust FY26 performance, with consolidated EBITDA rising to ₹9,253 crore and operational profit after tax (PAT) at ₹5,181 crore, up 50.3% year‑on‑year. The company’s ex‑US markets outpaced the rest of the business, posting 21% YoY revenue growth, while disciplined execution expanded full‑year EBITDA margin to 19%, up 140 basis points from FY25. […]
Article by: IMT News Desk
Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk